Acanthocytes;A11.118.413.330.100;A11.118.290.330.100
Acanthocytes;A15.145.229.413.330.100;A15.145.229.334.330.100
Acidulated Phosphate Fluoride;;D25.223.015
Acrosome;;A11.284.195.190.875.190.550.040
Adenoma, Adrenal Cortical;;C04.588.322.078.265.500
Adenoma, Adrenal Cortical;;C19.053.098.265.500
Adenoma, Adrenal Cortical;;C19.344.078.265.500
Ampicillin Resistance;G05.386.310.100.600.050;
Ampicillin Resistance;G05.706.310.100.600.050;
Anaplasia;C23.550.066;C23.550.727.045
Androblastoma;;C04.588.322.455.265
Androblastoma;;C04.588.945.418.685.148
Androblastoma;;C13.371.056.630.705.132
Androblastoma;;C13.371.270.750.124
Androblastoma;;C13.371.820.800.418.685.132
Androblastoma;;C19.344.455.265
Androblastoma;;C19.391.630.705.132
Aneuploidy;;C23.550.210.131
Animal Testing Alternatives;H01.770.644.045;H01.770.644.067.050
Animals;;B01.030
Animals, Congenic;;B01.030.157.040
Animals, Congenic;;B01.030.199.040
Animals, Domestic;;B01.030.116
Animals, Inbred Strains;;B01.030.157
Animals, Laboratory;;B01.030.199
Animals, Newborn;;B01.030.282
Animals, Poisonous;;B01.030.286
Animals, Suckling;;B01.030.291
Animals, Transgenic;;B01.030.199.085
Animals, Transgenic;;B01.030.296
Animals, Transgenic;;B01.030.724.500
Animals, Wild;;B01.030.300
Animals, Zoo;;B01.030.448
Anticodon;;G05.331.508.060
Anticodon;;G05.331.599.110.030
Anticodon;;G06.184.599.110.030
Aortic Subvalvular Stenosis;C14.280.600.100.095;C14.280.484.150.070
Aprocarb;D02.241.081.251.093;D02.241.081.251.650
Asparagine;;D12.125.154.049
Autoradiography;E05.909.262.105;E05.200.500.105
Autoradiography;E05.909.432.132;E05.200.750.132
Axons;;A11.284.180.075
Babesia;B01.841.075.762.580.580.070;B01.841.075.600.580.070
Babesia bovis;B01.841.075.762.580.580.070.100;B01.841.075.600.580.070.100
Babesiosis;C03.752.750.113;
Bacterial Chromatophores;A11.368.702.080;A11.284.195.190.875.080
Bacterial Typing Techniques;E05.909.560.150.125;E05.200.875.150.125
Bacteriological Techniques;E05.909.560.150;E05.200.875.150
Bacteriophage Typing;E05.909.560.150.125.150;E05.200.875.150.125.150
beta-Lactam Resistance;G05.386.310.100;
beta-Lactam Resistance;G05.706.310.100;
beta-N-Acetylhexosaminidase;D08.586.348.150;
Blackwater Fever;C03.752.750.259.552.650.228;C03.752.250.552.650.228
Blast Crisis;;C23.550.727.152.110
Blister;;C23.300.122
Blood Cell Count;E05.909.262.195.107;E05.200.500.195.107
Blood-Air Barrier;A11.195.443.025;
Blood-Aqueous Barrier;A11.195.443.037;
Blood-Brain Barrier;A11.195.443.050;
Blood-Retinal Barrier;A11.195.443.060;
Blood-Testis Barrier;A11.195.443.100;
Body Height;E05.118.176;E05.118.090.087
Body Weight;E05.118.287;E05.118.090.287
Bone Demineralization Technique;E05.909.432.210;E05.200.750.210
Brenner Tumor;;C04.588.945.418.685.297
Brenner Tumor;;C13.371.056.630.705.265
Brenner Tumor;;C13.371.270.750.249
Brenner Tumor;;C13.371.820.800.418.685.265
Brenner Tumor;;C19.391.630.705.265
Bronchi;A04.125;A04.411.125
Calsequestrin;;D12.776.157.125.155
Cancer Vaccines;D12.776.828.868.200;
Cancer Vaccines;D24.310.894.865.200;
Cancer Vaccines;D24.611.216.865.200;
Carcinoma, Adrenal Cortical;;C04.588.322.078.265.750
Carcinoma, Adrenal Cortical;;C19.053.098.265.750
Carcinoma, Adrenal Cortical;;C19.344.078.265.750
Carcinoma, Islet Cell;;C04.588.274.761.500
Carcinoma, Islet Cell;;C06.240.761.500
Carcinoma, Islet Cell;;C06.689.667.500
Cardiomyopathy, Hypertrophic;;C14.280.484.150.070.160
CD4 Lymphocyte Count;E05.909.262.195.107.595.500.150;E05.200.500.195.107.595.500.150
CD4-CD8 Ratio;E05.909.262.195.107.595.500.150.160;E05.200.500.195.107.595.500.150.160
Cell Count;E05.909.262.195;E05.200.500.195
Cell Culture;E05.909.813.225;E05.200.937.225
Cell Degranulation;G04.335.143;G04.335.532.160
Cell Fractionation;E05.909.262.251;E05.200.500.251
Cell Fusion;E05.909.262.307;E05.200.500.307
Cell Membrane;A11.195;A11.284.149
Cell Nucleolus;A11.223.210;A11.284.170.279.175
Cell Nucleus;A11.223;A11.284.170
Cell Nucleus;;A11.284.195.190.875.117
Cell Separation;E05.909.262.363;E05.200.500.363
Cell Transformation, Neoplastic;G04.335.349;C23.550.727.152
Cell Transformation, Viral;G05.386.185;C04.697.152.160
Cell Transformation, Viral;G05.825.700.210;C23.550.727.152.160
Cell Wall;A11.195.185;A11.284.295.154
Cell Wall Skeleton;A11.195.185.200;A11.284.295.154.200
Cell-Free System;A11.904.168;A11.284.835.168
Centrioles;A11.368.702.150.130;A11.284.195.190.750.585.160.130
Centromere;A11.223.475.135;A11.284.170.279.190.160.165
Centrosome;A11.368.702.150;A11.284.195.190.750.585.160
Cephalosporin Resistance;G05.386.310.100.175;
Cephalosporin Resistance;G05.706.310.100.175;
Chickenpox Vaccine;D24.310.894.899.130;D24.310.894.899.290.130
Chimera;G05.148.630.218;B01.030.530
Chimera;;B02.158.530
Chimera;;B06.085
Chlamydia pneumoniae;B03.440.190.190.190.600;B03.440.190.190.230.249
Chlamydia psittaci;B03.440.190.190.190.610;B03.440.190.190.230.500
Chloramphenicol Resistance;G05.386.310.202;
Chloramphenicol Resistance;G05.706.310.202;
Chloroform;;D02.455.526.913.810
Chloroplasts;A11.368.702.700.140;A11.284.195.190.875.700.140
Choroid Neoplasms;C04.588.443.363.978.223;
Chromaffin Granules;A11.368.246.207;A11.284.195.190.500.207
Chromaffin Granules;;A11.284.195.190.875.190.190.207
Chromatids;A11.223.475.144;A11.284.170.279.190.160.175
Chromatin;A11.223.349;A11.284.170.279.190.160.180
Chromatin;D12.776.660.224;
Chromosome Aberrations;;C23.550.210
Chromosome Banding;E05.909.262.385.130;E05.200.500.385.130
Chromosome Banding;E05.909.262.620.670.130;E05.200.500.620.670.130
Chromosome Banding;E05.909.432.600.670.130;E05.200.750.600.670.130
Chromosome Breakage;;C23.550.210.280
Chromosome Deletion;;C23.550.210.300
Chromosome Fragility;;C23.550.210.312
Chromosome Painting;;E05.200.500.620.670.325.350.125
Chromosome Painting;;E05.200.750.600.670.325.350.125
Chromosomes;A11.223.475;A11.284.170.279.190
Chromosomes;;A11.284.187
Chromosomes, Archaeal;A11.223.475.167;A11.284.187.167
Chromosomes, Bacterial;A11.223.475.190;A11.284.187.190
Chromosomes, Fungal;A11.223.475.360;A11.284.187.360
Chromosomes, Human;A11.223.475.480;A11.284.187.480
Chromosomes, Human, 1-3;A11.223.475.480.235;A11.284.187.480.235
Chromosomes, Human, 13-15;A11.223.475.480.370;A11.284.187.480.370
Chromosomes, Human, 16-18;A11.223.475.480.415;A11.284.187.480.415
Chromosomes, Human, 19-20;A11.223.475.480.460;A11.284.187.480.460
Chromosomes, Human, 21-22;A11.223.475.480.505;A11.284.187.480.505
Chromosomes, Human, 4-5;A11.223.475.480.280;A11.284.187.480.280
Chromosomes, Human, 6-12;A11.223.475.480.325;A11.284.187.480.325
Chromosomes, Human, Pair 1;A11.223.475.480.235.240;A11.284.187.480.235.240
Chromosomes, Human, Pair 10;A11.223.475.480.325.350;A11.284.187.480.325.350
Chromosomes, Human, Pair 11;A11.223.475.480.325.355;A11.284.187.480.325.355
Chromosomes, Human, Pair 12;A11.223.475.480.325.360;A11.284.187.480.325.360
Chromosomes, Human, Pair 13;A11.223.475.480.370.375;A11.284.187.480.370.375
Chromosomes, Human, Pair 14;A11.223.475.480.370.380;A11.284.187.480.370.380
Chromosomes, Human, Pair 15;A11.223.475.480.370.385;A11.284.187.480.370.385
Chromosomes, Human, Pair 16;A11.223.475.480.415.420;A11.284.187.480.415.420
Chromosomes, Human, Pair 17;A11.223.475.480.415.425;A11.284.187.480.415.425
Chromosomes, Human, Pair 18;A11.223.475.480.415.430;A11.284.187.480.415.430
Chromosomes, Human, Pair 19;A11.223.475.480.460.465;A11.284.187.480.460.465
Chromosomes, Human, Pair 2;A11.223.475.480.235.245;A11.284.187.480.235.245
Chromosomes, Human, Pair 20;A11.223.475.480.460.470;A11.284.187.480.460.470
Chromosomes, Human, Pair 21;A11.223.475.480.505.510;A11.284.187.480.505.510
Chromosomes, Human, Pair 22;A11.223.475.480.505.515;A11.284.187.480.505.515
Chromosomes, Human, Pair 3;A11.223.475.480.235.250;A11.284.187.480.235.250
Chromosomes, Human, Pair 4;A11.223.475.480.280.285;A11.284.187.480.280.285
Chromosomes, Human, Pair 5;A11.223.475.480.280.290;A11.284.187.480.280.290
Chromosomes, Human, Pair 6;A11.223.475.480.325.330;A11.284.187.480.325.330
Chromosomes, Human, Pair 7;A11.223.475.480.325.335;A11.284.187.480.325.335
Chromosomes, Human, Pair 8;A11.223.475.480.325.340;A11.284.187.480.325.340
Chromosomes, Human, Pair 9;A11.223.475.480.325.345;A11.284.187.480.325.345
Chromosomes, Yeast Artificial;A11.223.475.360.800;A11.284.187.178.200
Chromosomes, Yeast Artificial;;A11.284.187.360.800
Chromosomes, Yeast Artificial;;D13.444.308.460.320.165.200
Cilia;A11.368.702.155;A11.284.180.165
Cloning, Molecular;G05.331.120;
Coated Pits, Cell-Membrane;A11.195.190;A11.284.149.165.175
Coated Vesicles;A11.368.702.160;A11.284.195.190.875.190.880.180
Cocarcinogenesis;C23.550.225;C23.550.727.160
Coccidia;B01.841.075.762.167;B01.841.075.189
Coccidiosis;C03.752.750.259;C03.752.250
Coculture;E05.909.813.250;E05.200.937.250
Codon;;G05.331.508.355
Codon;;G05.331.599.110.355
Codon;;G06.184.599.110.355
Codon, Initiator;;G05.331.508.355.225
Codon, Initiator;;G05.331.599.110.355.225
Codon, Initiator;;G06.184.599.110.355.225
Codon, Nonsense;D13.444.735.544.355.235;D13.444.735.544.355.250.235
Codon, Nonsense;;G05.331.508.355.250.235
Codon, Nonsense;;G05.331.599.110.355.250.235
Codon, Nonsense;;G05.632.120
Codon, Nonsense;;G06.184.599.110.355.250.235
Codon, Terminator;;G05.331.508.355.250
Codon, Terminator;;G05.331.599.110.355.250
Codon, Terminator;;G06.184.599.110.355.250
Coiled Bodies;A11.223.480;A11.284.170.279.195
Colony Count, Microbial;E05.909.560.220;E05.200.875.220
Colony-Forming Units Assay;E05.909.262.383;E05.200.500.383
Conjugation, Genetic;G05.825.192;G05.825.390.249
Conjunctival Neoplasms;C04.588.443.363.235;
Consensus Sequence;G05.331.599.056.160;G05.331.599.250.175
Consensus Sequence;G05.331.599.110.200;G06.184.599.250.175
Consensus Sequence;G06.184.599.056.160;
Consensus Sequence;G06.184.599.110.200;
Corrosion Casting;E05.909.262.620.620.150;E05.200.500.620.620.150
Corrosion Casting;E05.909.432.600.620.150;E05.200.750.600.620.150
Cryopreservation;E05.909.262.620.760.160;E05.200.500.620.760.160
Cryopreservation;E05.909.432.600.760.160;E05.200.750.600.760.160
Cryoultramicrotomy;E05.909.262.620.530.160;E05.200.500.620.530.160
Cryoultramicrotomy;E05.909.432.600.530.160;E05.200.750.600.530.160
Cryptosporidiosis;C03.752.750.259.269;C03.752.250.269
Cryptosporidium;B01.841.075.762.167.275.250.087;B01.841.075.189.250.150.160
Cryptosporidium parvum;B01.841.075.762.167.275.250.087.500;B01.841.075.189.250.150.160.170
Cysteine;;D12.125.154.299
Cytapheresis;E05.909.262.363.285;E05.200.500.363.285
Cytogenetic Analysis;E05.909.262.385;E05.200.500.385
Cytological Techniques;E05.909.262;E05.200.500
Cytophotometry;E05.909.262.386;E05.200.500.386
Cytoplasm;A11.368;A11.284.195
Cytoplasmic Granules;A11.368.246;A11.284.195.190.500
Cytoplasmic Granules;A11.515.246;A11.284.195.190.875.190.190
Cytoskeleton;A11.368.250;A11.284.195.190.750
Cytosol;A11.904.287;A11.284.195.200
Cytosol;;A11.284.835.287
Decalcification Technique;E05.909.432.288;E05.200.750.288
Dendrites;;A11.284.180.225
Desmosomes;A11.195.443.297;A11.284.149.165.420.297
Diabetes, Gestational;C13.703.766.285;C13.703.170
Diabetes, Gestational;C18.452.297.820.285;C18.452.297.200
Diabetes, Gestational;C19.246.820.285;C19.246.200
DIDS;D02.455.426.559.389.150.700.150;D02.455.426.559.389.150.700.200
Diffusion Chambers, Culture;E05.909.262.387;E05.200.500.387
Diffusion Chambers, Culture;E05.909.813.387;E05.200.937.387
Diphtheria Toxoid;D24.310.794.263;D24.310.894.691.263
Diphtheria-Tetanus-Pertussis Vaccine;D24.310.794.263.300;D24.310.894.135.300
Diphtheria-Tetanus-Pertussis Vaccine;D24.310.794.824.300;D24.310.894.691.263.300
Diphtheria-Tetanus-Pertussis Vaccine;D24.310.894.135.378;D24.310.894.691.824.300
Diverticulosis, Colonic;;C06.273.124
Diverticulosis, Colonic;;C23.300.415.124
Diverticulum;C06.405.748.142;C06.273
DNA Footprinting;;E05.393.600.300
DNA, Chloroplast;D13.444.308.275;D13.444.308.283.170
DNA, Kinetoplast;D13.444.308.283.200;D13.444.308.283.225.200
DNA, Kinetoplast;D13.444.308.354.200;
DNA, Kinetoplast;D13.444.600.223.520;
DNA, Kinetoplast;D26.600.530.600.223.490;
DNA, Mitochondrial;D13.444.308.354;D13.444.308.283.225
Drug Evaluation;E05.337.300.200;E05.337.425
Drug Resistance, Microbial;G05.386.310;
Drug Resistance, Microbial;G05.706.310;
Drug Screening;E05.337.300.250;E05.337.550
Drug Screening Assays, Antitumor;E05.337.300.250.200;E05.200.500.388
Drug Screening Assays, Antitumor;E05.909.262.388;E05.337.550.200
Echocardiography, Four-Dimensional;;E01.370.350.400.200.230
Echocardiography, Three-Dimensional;;E01.370.350.400.200
Eimeria;B01.841.075.762.167.275.250.276;B01.841.075.189.250.250.250
Eimeria tenella;B01.841.075.762.167.275.250.276.650;B01.841.075.189.250.250.250.250
Electron Spin Resonance Spectroscopy;E05.196.867.303;E05.196.867.519.274
Electron Spin Resonance Spectroscopy;H01.671.579.340;H01.671.579.631.240
Electroporation;E05.909.262.410;E05.200.500.410
Endoplasmic Reticulum;A11.368.702.248;A11.284.195.190.875.248
Endoplasmic Reticulum, Rough;A11.368.702.248.300;A11.284.195.190.875.248.300
Endoplasmic Reticulum, Rough;;A11.284.195.190.875.811.740.300
Endoplasmic Reticulum, Smooth;A11.368.702.248.310;A11.284.195.190.875.248.310
Endosomes;A11.368.702.160.260;A11.284.195.190.875.190.250
EPN;D02.719.376;D02.719.750
Erythroblasts;A11.118.413.350.200;A11.118.290.350.200
Erythroblasts;A11.148.378.350.200;A11.148.378.590.249.200
Erythroblasts;A15.145.229.413.350.200;A15.145.229.334.665.200
Erythroblasts;A15.378.316.378.350.200;A15.378.316.378.590.249.200
Erythrocyte Count;E05.909.262.195.107.330;E05.200.500.195.107.330
Erythrocyte Inclusions;A11.118.413.330.340;A11.118.290.330.315
Erythrocyte Inclusions;A15.145.229.413.330.340;A11.284.420.204
Erythrocyte Inclusions;;A15.145.229.334.330.340
Erythrocyte Membrane;A11.118.413.270;A11.118.290.270
Erythrocyte Membrane;A11.195.356;A11.284.149.356
Erythrocyte Membrane;A15.145.229.413.270;A15.145.229.334.270
Erythrocytes;A11.118.413;A11.118.290
Erythrocytes;A15.145.229.413;A15.145.229.334
Erythrocytes, Abnormal;A11.118.413.330;A11.118.290.330
Erythrocytes, Abnormal;A15.145.229.413.330;A15.145.229.334.330
Erythroid Progenitor Cells;A11.118.413.350;A11.118.290.350
Erythroid Progenitor Cells;A11.148.378.350;A11.148.378.590.249
Erythroid Progenitor Cells;A11.872.378.350;A11.872.378.590.270
Erythroid Progenitor Cells;A15.145.229.413.350;A15.145.229.334.665
Erythroid Progenitor Cells;A15.378.316.378.350;A15.378.316.378.590.249
Esophageal Diverticulum;;C06.273.250
Eucoccidiida;B01.841.075.762.167.275;B01.841.075.189.275
Extracellular Matrix;A11.470.310;A11.284.295.310
Extracellular Space;A11.470;A11.284.295
Eye Neoplasms;C04.588.443.363;
Eyelid Neoplasms;C04.588.364.421;C04.588.443.392.500
Eyelid Neoplasms;C04.588.443.363.421;
Fetal Macrosomia;C13.703.766.570;C18.452.297.200.250
Fetal Macrosomia;;C19.246.200.250
Fetal Weight;E05.118.287.300;E05.118.090.287.300
Fimbriae, Bacterial;A11.368.702.292;A11.284.180.285
Fishes, Poisonous;;B01.030.286.400
Flagella;A11.368.702.298;A11.284.180.290
Flow Cytometry;E05.909.262.386.350;E05.200.500.386.350
Fluorescent Antibody Technique;E05.909.432.551.512.240;E05.200.750.551.512.240
Fluorescent Antibody Technique, Direct;E05.909.432.551.512.240.300;E05.200.750.551.512.240.300
Fluorescent Antibody Technique, Indirect;E05.909.432.551.512.240.310;E05.200.750.551.512.240.310
Freemartinism;G05.148.630.437;C13.371.820.700.842.260
Freemartinism;;C16.131.939.842.260
Freemartinism;;C19.391.775.260
Freeze Drying;E05.909.262.620.760.160.260;E05.200.500.620.760.160.260
Freeze Drying;E05.909.432.600.760.160.260;E05.200.750.600.760.160.260
Freeze Etching;E05.909.262.620.620.260.400;E05.200.500.620.620.260.400
Freeze Etching;E05.909.432.600.620.260.400;E05.200.750.600.620.260.400
Freeze Fracturing;E05.909.262.620.620.260;E05.200.500.620.620.260
Freeze Fracturing;E05.909.432.600.620.260;E05.200.750.600.620.260
Freeze Substitution;E05.909.262.620.760.160.260.270;E05.200.500.620.760.160.260.270
Freeze Substitution;E05.909.432.600.760.160.260.270;E05.200.750.600.760.160.260.270
Frozen Sections;E05.909.262.620.530.160.260;E05.200.500.620.530.160.260
Frozen Sections;E05.909.432.600.530.160.260;E05.200.750.600.530.160.260
Gap Junctions;A11.195.443.471;A11.284.149.165.420.471
Gastrospirillum hominis;B03.440.375.375;B03.440.500.274
Gastrospirillum hominis;B03.660.150.250.280;B03.660.150.280.274
Gastrospirillum hominis;B03.825.380.375;B03.825.400.274
Gene Amplification;E05.393.330;E05.393.620.249
Gene Rearrangement;G04.610.626.321;
Gene Rearrangement;G05.511.321;
Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor;G04.610.626.321.801.111;G04.610.626.325.111
Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor;G05.511.321.801.111;G05.511.325.111
Gene Rearrangement, B-Lymphocyte;G04.610.626.321.401;G04.610.626.320
Gene Rearrangement, B-Lymphocyte;G05.511.321.401;G05.511.320
Gene Rearrangement, B-Lymphocyte, Heavy Chain;G04.610.626.321.401.501;G04.610.626.320.501
Gene Rearrangement, B-Lymphocyte, Heavy Chain;G05.511.321.401.501;G05.511.320.501
Gene Rearrangement, B-Lymphocyte, Light Chain;G04.610.626.321.401.601;G04.610.626.320.601
Gene Rearrangement, B-Lymphocyte, Light Chain;G05.511.321.401.601;G05.511.320.601
Gene Rearrangement, beta-Chain T-Cell Antigen Receptor;G04.610.626.321.801.211;G04.610.626.325.211
Gene Rearrangement, beta-Chain T-Cell Antigen Receptor;G05.511.321.801.211;G05.511.325.211
Gene Rearrangement, delta-Chain T-Cell Antigen Receptor;G04.610.626.321.801.261;G04.610.626.325.261
Gene Rearrangement, delta-Chain T-Cell Antigen Receptor;G05.511.321.801.261;G05.511.325.261
Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor;G04.610.626.321.801.311;G04.610.626.325.311
Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor;G05.511.321.801.311;G05.511.325.311
Gene Rearrangement, T-Lymphocyte;G04.610.626.321.801;G04.610.626.325
Gene Rearrangement, T-Lymphocyte;G05.511.321.801;G05.511.325
Gentamicins;D27.505.093.374;
Glutamate Synthase;;D08.586.682.135.470
Glutamine;;D12.125.154.424
Glycocalyx;A11.195.399;A11.284.149.165.355
Glyoxysomes;A11.368.702.515.250;A11.284.195.190.500.585.250
Glyoxysomes;;A11.284.195.190.875.190.190.755.250
Golgi Apparatus;A11.368.702.336;A11.284.195.190.875.336
Granulocytes;;A11.118.835.249
Granulocytes;;A11.148.378.590.590.500
Granulocytes;;A15.145.229.698.249
Granulocytes;;A15.378.316.378.590.590.500
Granulosa Cell Tumor;;C04.588.322.455.398
Granulosa Cell Tumor;;C04.588.945.418.685.446
Granulosa Cell Tumor;;C13.371.056.630.705.398
Granulosa Cell Tumor;;C13.371.270.750.374
Granulosa Cell Tumor;;C13.371.820.800.418.685.398
Granulosa Cell Tumor;;C19.344.455.398
Granulosa Cell Tumor;;C19.391.630.705.398
Growth Cones;;A11.284.180.075.249
Growth Cones;;A11.284.180.225.340
Growth Cones;;A11.284.180.610.345
Growth Cones;;A11.671.137.340
Growth Cones;;A11.671.240.340
Haemosporina;B01.841.075.762.167.275.400;B01.841.075.380
Haplotypes;G05.470;G05.441.360
Heinz Bodies;A11.118.413.330.340.335;A11.118.290.330.315.335
Heinz Bodies;A15.145.229.413.330.340.335;A11.284.420.204.335
Heinz Bodies;;A15.145.229.334.330.340.335
Hela Cells;A11.251.353.460;
Hemodiafiltration;E02.912.390.200;E02.912.800.200
Hemodialysis;E02.912.390;E02.912.800
Hemodialysis, Home;E02.912.390.300;E02.912.800.300
Hemolysis;;C23.550.403
Heterochromatin;A11.223.349.383;A11.284.170.279.190.160.180.383
Heterochromatin;D12.776.660.224.460;
Hindlimb Suspension;;E05.977.400
Hindlimb Suspension;;G03.230.150.440.950.400
Histocytochemistry;E05.909.262.607;E05.200.500.607
Histocytochemistry;E05.909.432.551;E05.200.750.551
Histocytological Preparation Techniques;E05.909.262.620;E05.200.500.620
Histocytological Preparation Techniques;E05.909.432.600;E05.200.750.600
Histological Techniques;E05.909.432;E05.200.750
Holography;;E01.370.350.400.500
25-Hydroxycholecalciferol 1-Hydroxylase;;D08.262.453.400
Hydroxymethylglutaryl-CoA Reductase Inhibitors;;D10.162.202.370
Hydroxymethylglutaryl-CoA Reductase Inhibitors;;D27.505.519.162.202.370
Image Cytometry;E05.909.262.386.400;E05.200.500.386.400
Immunoglobulin Allotypes;G04.610.626.500;G04.610.626.398.300
Immunoglobulin Allotypes;G05.275.077.500;G05.275.351.300
Immunoglobulin Class Switching;G04.610.626.321.900;G04.610.626.320.501.450
Immunoglobulin Class Switching;G05.331.390.900;G05.331.390.401.501.450
Immunoglobulin Class Switching;G05.511.321.900;G05.511.320.501.450
Immunoglobulin Gm Allotypes;G04.610.626.500.504;G04.610.626.398.300.504
Immunoglobulin Gm Allotypes;G05.275.077.500.495;G05.275.351.300.495
Immunoglobulin Inv Allotypes;G04.610.626.500.507;G04.610.626.398.300.507
Immunoglobulin Inv Allotypes;G05.275.077.500.505;G05.275.351.300.505
Immunohistochemistry;E05.909.262.607.512;E05.200.500.607.512
Immunohistochemistry;E05.909.432.551.512;E05.200.750.551.512
Immunomagnetic Separation;E02.110.142.400;E05.200.500.363.400
Immunomagnetic Separation;E05.909.262.363.400;
In Situ Hybridization;;E05.200.500.620.670.325
In Situ Hybridization;;E05.200.750.600.670.325
In Situ Hybridization, Fluorescence;;E05.200.500.620.670.325.350
In Situ Hybridization, Fluorescence;;E05.200.750.600.670.325.350
Inclusion Bodies;A11.515;A11.284.420
Inclusion Bodies, Viral;A11.515.410;A11.284.420.410
Insecticide Resistance;G05.706.574;
Intercellular Junctions;A11.195.443;A11.284.149.165.420
Intermediate Filaments;A11.368.250.410;A11.284.195.190.750.410
Intracellular Membranes;A11.904.514;A11.284.149.450
Intracellular Membranes;;A11.284.835.514
Introns;G05.331.599.110.505;G05.331.599.110.275.400
Introns;G06.184.599.110.505;G06.184.599.110.220.410
Inulin;;D09.203.698.365.855.750
Inversion (Genetics);;C23.550.210.445
Iris Neoplasms;C04.588.443.363.978.400;
ISCOMs;D12.776.828.868.400;D24.310.894.860.449
ISCOMs;D24.310.894.865.400;
ISCOMs;D24.611.216.865.400;
Isochromosomes;;C23.550.210.460
Isospora;B01.841.075.762.167.275.250.467;B01.841.075.189.250.250.400
Jaw Neoplasms;C04.588.443.840.450;
Jet Lag Syndrome;;C10.281.440
Kanamycin Resistance;G05.386.310.493;
Kanamycin Resistance;G05.706.310.493;
Karyometry;E05.909.262.695;E05.200.500.695
KB Cells;A11.251.353.501;
Kidney, Polycystic;C04.182.394.420;C04.182.394.600
Kidney, Polycystic;C12.740.700.608;C12.740.700.800
Kidney, Polycystic;C12.777.419.413.420;C12.777.419.413.600
Kidney, Polycystic;C13.371.820.700.608;C13.371.820.700.800
Kidney, Polycystic;C16.131.939.608;C16.131.939.800
Kidney, Polycystic, Autosomal Dominant;C04.182.394.420.500;C04.182.394.600.500
Kidney, Polycystic, Autosomal Dominant;C12.740.700.608.500;C12.740.700.800.500
Kidney, Polycystic, Autosomal Dominant;C12.777.419.413.420.500;C12.777.419.413.600.500
Kidney, Polycystic, Autosomal Dominant;C13.371.820.700.608.500;C13.371.820.700.800.500
Kidney, Polycystic, Autosomal Dominant;C16.131.939.608.500;C16.131.939.800.500
Kidney, Polycystic, Autosomal Recessive;C04.182.394.420.510;C04.182.394.600.510
Kidney, Polycystic, Autosomal Recessive;C12.740.700.608.510;C12.740.700.800.510
Kidney, Polycystic, Autosomal Recessive;C12.777.419.413.420.510;C12.777.419.413.600.510
Kidney, Polycystic, Autosomal Recessive;C13.371.820.700.608.510;C13.371.820.700.800.510
Kidney, Polycystic, Autosomal Recessive;C16.131.939.608.510;C16.131.939.800.510
Kidney, Sponge;C12.777.419.413.586;C12.777.419.413.200
Kinetics;;G12.561
Kinetochores;A11.223.475.135.500;A11.284.170.279.190.160.165.500
Leukapheresis;E05.909.262.363.285.570;E05.200.500.363.285.570
Leukemic Infiltration;;C23.550.727.645.500
Leukocyte Count;E05.909.262.195.107.595;E05.200.500.195.107.595
Lewy Bodies;A11.368.600;A11.284.420.460
Lewy Bodies;A11.515.460;
Limulus Test;E05.909.560.150.570;E05.200.875.150.570
Liposomes;;D26.664.255.260.517
Liposomes;;D27.720.280.260.517
Lipoxygenase;D08.586.348.600;
Loss of Heterozygosity;G05.632.490;C23.550.210.300.520
Loss of Heterozygosity;;G05.632.040.530
Luteoma;;C04.588.322.455.464
Luteoma;;C04.588.945.418.685.520
Luteoma;;C13.371.056.630.705.464
Luteoma;;C13.371.270.750.437
Luteoma;;C13.371.820.800.418.685.464
Luteoma;;C19.344.455.464
Luteoma;;C19.391.630.705.464
Lymphatic Metastasis;;C23.550.727.650.560
Lymphocyte Count;E05.909.262.195.107.595.500;E05.200.500.195.107.595.500
Lysosomes;A11.368.702.452;A11.284.195.190.875.190.550
Malaria;C03.752.750.259.552;C03.752.250.552
Malaria Vaccines;D12.776.828.868.500;
Malaria Vaccines;D24.310.894.865.500;
Malaria Vaccines;D24.611.216.865.500;
Malaria, Avian;C03.752.750.259.552.606;C03.752.250.552.606
Malaria, Falciparum;C03.752.750.259.552.650;C03.752.250.552.650
Malaria, Vivax;C03.752.750.259.552.700;C03.752.250.552.700
Mandibular Neoplasms;C04.588.443.840.450.550;
Maxillary Neoplasms;C04.588.443.840.450.560;
Meckel's Diverticulum;;C06.273.250.455
Megakaryocytes;A11.148.614;A11.148.378.590.249.480
Megakaryocytes;A15.378.316.614;A15.378.316.378.590.249.480
Megaloblasts;A11.118.413.330.531;A11.118.290.330.531
Megaloblasts;A15.145.229.413.330.531;A15.145.229.334.330.531
Melanosomes;A11.368.246.560;A11.284.195.190.500.560
Melanosomes;A11.368.702.500;A11.284.195.190.875.190.190.560
Methicillin Resistance;G05.386.310.100.600.525;
Methicillin Resistance;G05.706.310.100.600.525;
Methionine;;D12.125.154.549
Mice, Congenic;;B01.030.199.040.500
Mice, Inbred A;;B01.030.157.250.300
Mice, Inbred AKR;;B01.030.157.250.318
Mice, Inbred BALB C;;B01.030.157.250.338
Mice, Inbred C3H;;B01.030.157.250.388
Mice, Inbred C57BL;;B01.030.157.250.420
Mice, Inbred CBA;;B01.030.157.250.440
Mice, Inbred CFTR;;B01.030.157.250.445
Mice, Inbred DBA;;B01.030.157.250.460
Mice, Inbred HRS;;B01.030.157.250.480
Mice, Inbred ICR;;B01.030.157.250.510
Mice, Inbred mdx;;B01.030.157.250.420.500
Mice, Inbred MRL lpr;;B01.030.157.250.555
Mice, Inbred NZB;;B01.030.157.250.580
Mice, Inbred SENCAR;;B01.030.157.250.600
Mice, Inbred Strains;;B01.030.157.250
Mice, Transgenic;;B01.030.199.085.600
Mice, Transgenic;;B01.030.296.600
Mice, Transgenic;;B01.030.724.500.600
Microbial Sensitivity Tests;E05.909.560.595;E05.200.875.595
Microbial Sensitivity Tests;;E05.337.550.400
Microbiological Techniques;E05.909.560;E05.200.875
Microbodies;A11.368.702.515;A11.284.195.190.500.585
Microbodies;;A11.284.195.190.875.190.190.755
Microfibrils;A11.470.310.500;A11.284.295.310.560
Microfilaments;A11.368.250.510;A11.284.195.190.750.510
Micronuclei;A11.630;A11.284.170.555
Micronuclei;;A11.284.195.190.875.117.555
Micronutrients;J02.500.625;D11.430
Microsomes;A11.904.540;A11.284.835.540
Microsomes, Liver;A11.904.540.541;A11.284.835.540.541
Microtomy;E05.909.262.620.530;E05.200.500.620.530
Microtomy;E05.909.432.600.530;E05.200.750.600.530
Microtubules;A11.368.250.602;A11.284.195.190.750.602
Microvilli;A11.195.590;A11.284.180.565
Mitochondria;A11.368.702.564;A11.284.195.190.875.564
Mitochondria;A11.904.626;A11.284.835.626
Mitochondria, Heart;A11.368.702.564.627.603;A11.284.195.190.875.564.627.603
Mitochondria, Heart;A11.904.626.627.603;A11.284.835.626.627.603
Mitochondria, Liver;A11.368.702.564.461;A11.284.195.190.875.564.461
Mitochondria, Liver;A11.904.626.461;A11.284.835.626.461
Mitochondria, Muscle;A11.368.702.564.627;A11.284.195.190.875.564.627
Mitochondria, Muscle;A11.904.626.627;A11.284.835.626.627
Mitotic Index;E05.909.262.385.500;E05.200.500.385.500
Mitotic Spindle Apparatus;A11.368.702.581;A11.284.195.190.750.610
Monocytes;;A11.118.835.624
Monocytes;;A11.148.378.590.590.750
Monocytes;;A15.145.229.698.624
Monocytes;;A15.378.316.378.590.590.750
Monocytes, Activated Killer;;A11.118.835.624.500
Monocytes, Activated Killer;;A15.145.229.698.624.500
Monosomy;;C23.550.210.131.500
Mossy Fibers, Hippocampal;A11.195.443.780.700.500;A11.671.137.560
Mossy Fibers, Hippocampal;A11.671.137.750.500;
Motor Endplate;A11.195.443.780.550.550.500;A11.284.149.165.420.780.550.550.500
Mycological Typing Techniques;E05.909.560.610;E05.200.875.610
Myelin Sheath;;A11.284.149.165.600
Myofibrils;A11.368.702.619;A11.284.195.190.750.620
Negative Staining;E05.909.262.620.670.520;E05.200.500.620.670.520
Negative Staining;E05.909.432.600.670.520;E05.200.750.600.670.520
Neoplasm Circulating Cells;;C23.550.727.650.645
Neoplasm Invasiveness;;C23.550.727.645
Neoplasm Metastasis;;C23.550.727.650
Neoplasm Recurrence, Local;;C23.550.727.655
Neoplasm Regression, Spontaneous;;C23.550.727.670
Neoplasm Seeding;;C23.550.727.650.830
Neoplasm, Residual;;C23.550.727.700
Neoplasms, Unknown Primary;;C23.550.727.650.895
Neoplastic Processes;;C23.550.727
Neospora;B01.841.075.762.167.275.250.560;B01.841.075.189.250.750.550
Nephroma, Mesoblastic;;C04.588.945.947.535.790
Nephroma, Mesoblastic;;C12.740.800.820.750.790
Nephroma, Mesoblastic;;C12.777.419.473.790
Nephroma, Mesoblastic;;C13.371.820.800.820.535.790
Neurites;A11.671.137.500;A11.284.180.610
Neurites;A11.671.240.500;A11.671.543
Neurocytoma;;C04.588.614.250.195.648
Neurocytoma;;C10.228.140.211.692
Neurocytoma;;C10.551.240.250.550
Neuroeffector Junction;A11.195.443.780.550;A11.284.149.165.420.780.550
Neurofibrillary Tangles;A11.368.702.672.520;A11.284.195.190.750.640.520
Neurofibrils;A11.368.702.672;A11.284.195.190.750.640
Neuromuscular Junction;A11.195.443.780.550.550;A11.284.149.165.420.780.550.550
Neuropil Threads;;A11.284.195.190.750.602.620
Nissl Bodies;A11.368.702.248.441;A11.284.195.190.500.610
Nissl Bodies;;A11.284.195.190.875.248.300.610
Nissl Bodies;;A11.284.195.190.875.811.740.300.610
Nitric-Oxide Synthase;;D08.586.682.608.550.772
Nondisjunction, Genetic;;C23.550.210.645
Nose Neoplasms;C04.588.443.840.620;
Nuclear Localization Signal;G05.331.599.056.540;D12.644.770.610
Nuclear Localization Signal;G06.184.599.056.540;G05.331.599.056.670.610
Nuclear Localization Signal;;G06.184.599.056.670.610
Nuclear Matrix;A11.223.630;A11.284.170.279.700
Nuclear Membrane;A11.223.650;A11.284.149.165.630
Nuclear Membrane;A11.904.514.700;A11.284.149.450.700
Nuclear Membrane;;A11.284.170.279.692
Nuclear Membrane;;A11.284.835.514.700
Nucleolus Organizer Region;A11.223.475.658;A11.284.170.279.190.160.650
Nucleosomes;A11.223.349.625;A11.284.170.279.190.160.180.625
Nucleosomes;D12.776.660.224.550;
Orbital Neoplasms;C04.588.443.363.659;
Orbital Neoplasms;C04.588.443.840.660;
Organ Culture;E05.909.813.576;E05.200.937.576
Organelles;A11.368.702;A11.284.195.190.875
Organisms, Transgenic;;B01.030.724
Organoids;A11.700;A10.802
Ornithosis;C01.252.400.210.210.575;C01.252.400.210.250.600
Palatal Neoplasms;C04.588.443.840.450.690;
Palate;A02.835.232.781.324.502.658;
Papillary Muscles;;A02.633.580.680
Papillary Muscles;;A07.541.749
Paraffin Embedding;E05.909.262.620.720.610;E05.200.500.620.720.610
Paraffin Embedding;E05.909.432.600.720.610;E05.200.750.600.720.610
Patch-Clamp Techniques;E05.909.262.800;E05.200.500.800
Patch-Clamp Techniques;G07.453.774;
PC12 Cells;A11.251.353.750;A11.299.500
Penicillin Resistance;G05.386.310.100.600;
Penicillin Resistance;G05.706.310.100.600;
Peptide Mapping;;E05.393.760.705.685
Periodic Acid-Schiff Reaction;E05.909.262.607.790;E05.200.500.607.790
Periodic Acid-Schiff Reaction;E05.909.262.620.670.620;E05.200.500.620.670.620
Periodic Acid-Schiff Reaction;E05.909.432.551.790;E05.200.750.551.790
Periodic Acid-Schiff Reaction;E05.909.432.600.670.620;E05.200.750.600.670.620
Periplasm;A11.195.620;A11.284.295.680
Peritoneal Dialysis;E02.870.700;E02.870.300.650
Peritoneal Dialysis;E02.912.650;E02.912.800.650
Peritoneal Dialysis, Continuous Ambulatory;E02.870.700.500;E02.870.300.650.500
Peritoneal Dialysis, Continuous Ambulatory;E02.912.650.500;E02.912.800.650.500
Peroxisomes;A11.368.702.515.600;A11.284.195.190.500.585.600
Peroxisomes;;A11.284.195.190.875.190.190.755.600
Phagosomes;A11.368.702.677;A11.284.195.190.875.190.700
Philadelphia Chromosome;;C23.550.210.764.680
Phyllodes Tumor;;C04.588.180.762
Phyllodes Tumor;;C19.146.170.630
Pili, Sex;A11.368.702.679;A11.284.180.690
Pinealoma;;C04.588.614.250.195.766
Pinealoma;;C10.228.140.211.788
Pinealoma;;C10.551.240.250.625
Piroplasmia;B01.841.075.762.580;B01.841.075.600
Piroplasmida;B01.841.075.762.580.580;B01.841.075.600.580
Plaque Assay;E05.909.560.970.790;E05.200.875.970.790
Plasmodium;B01.841.075.762.167.275.400.611;B01.841.075.380.611
Plasmodium berghei;B01.841.075.762.167.275.400.611.461;B01.841.075.380.611.461
Plasmodium chabaudi;B01.841.075.762.167.275.400.611.490;B01.841.075.380.611.490
Plasmodium cynomolgi;B01.841.075.762.167.275.400.611.505;B01.841.075.380.611.505
Plasmodium falciparum;B01.841.075.762.167.275.400.611.561;B01.841.075.380.611.561
Plasmodium gallinaceum;B01.841.075.762.167.275.400.611.576;B01.841.075.380.611.576
Plasmodium knowlesi;B01.841.075.762.167.275.400.611.610;B01.841.075.380.611.610
Plasmodium malariae;B01.841.075.762.167.275.400.611.661;B01.841.075.380.611.661
Plasmodium vivax;B01.841.075.762.167.275.400.611.761;B01.841.075.380.611.761
Plasmodium yoelii;B01.841.075.762.167.275.400.611.780;B01.841.075.380.611.780
Plastic Embedding;E05.909.262.620.720.640;E05.200.500.620.720.640
Plastic Embedding;E05.909.432.600.720.640;E05.200.750.600.720.640
Plastids;A11.368.702.700;A11.284.195.190.875.700
Platelet Count;E05.909.262.195.107.740;E05.200.500.195.107.740
Plateletpheresis;E05.909.262.363.285.790;E05.200.500.363.285.790
Poliovirus Vaccine;D24.310.894.899.614;D24.310.894.830.614
Poliovirus Vaccine;;D24.310.894.899.623.500
Poliovirus Vaccine, Oral;D24.310.894.899.614.614;D24.310.894.899.623.750
Polymerase Chain Reaction;E05.393.330.500;E05.393.620.500
Polymorphism (Genetics);;G05.632.690
Polymorphism, Single Nucleotide;;G05.632.690.800
Polyribosomes;A11.368.702.248.300.651.740;A11.284.195.190.875.811.740
Polyribosomes;A11.368.702.811.740;
Presynaptic Terminals;A11.195.443.780.700;A11.284.149.165.420.780.700
Primed In Situ Labeling;E05.393.330.500.650;E05.200.500.620.670.325.680
Primed In Situ Labeling;;E05.200.750.600.670.325.680
Primed In Situ Labeling;;E05.393.620.500.650
Prussian Blue Reaction;E05.909.262.607.810;E05.200.500.607.810
Prussian Blue Reaction;E05.909.262.620.670.660;E05.200.500.620.670.660
Prussian Blue Reaction;E05.909.432.551.810;E05.200.750.551.810
Prussian Blue Reaction;E05.909.432.600.670.660;E05.200.750.600.670.660
Pseudopodia;A11.368.702.783;A11.284.180.700
Psychiatric Nursing;F04.096.544.628;
Pulmonary Adenomatosis, Ovine;C02.256.466.838;C02.782.815.725
Pulmonary Adenomatosis, Ovine;;C04.557.470.200.025.715
Pulmonary Blastoma;;C04.588.894.797.520.867
Pulmonary Subvalvular Stenosis;C14.280.600.100.715;C14.280.484.716.700
Purple Membrane;A11.195.648;A11.284.149.648
Radiation Chimera;G05.148.630.763;B01.030.530.750.760
Radiation Chimera;G05.800.638;B02.158.530.750.760
Randomized Controlled Trials;E05.318.760.535.750;E05.318.760.535.365.500
Randomized Controlled Trials;E05.337.250.750;E05.337.250.365.500
Randomized Controlled Trials;G03.850.520.835.535.750;G03.850.520.835.535.365.500
Randomized Controlled Trials;N05.715.360.775.235.700;N05.715.360.775.235.387.500
Ranvier's Nodes;;A11.284.149.165.760
Rats, Inbred ACI;;B01.030.157.500.080
Rats, Inbred BB;;B01.030.157.500.090
Rats, Inbred BN;;B01.030.157.500.110
Rats, Inbred BUF;;B01.030.157.500.130
Rats, Inbred Dahl;;B01.030.157.500.165
Rats, Inbred F344;;B01.030.157.500.200
Rats, Inbred LEC;;B01.030.157.500.275
Rats, Inbred Lew;;B01.030.157.500.280
Rats, Inbred OLETF;;B01.030.157.500.290
Rats, Inbred SHR;;B01.030.157.500.300
Rats, Inbred Strains;;B01.030.157.500
Rats, Inbred WF;;B01.030.157.500.360
Rats, Inbred WKY;;B01.030.157.500.390
Replica Techniques;E05.909.262.620.620;E05.200.500.620.620
Replica Techniques;E05.909.432.600.620;E05.200.750.600.620
Replication Origin;;G05.331.599.110.275.760
Replication Origin;;G06.184.599.110.220.760
Reticulocyte Count;E05.909.262.195.107.330.725;E05.200.500.195.107.330.725
Reticulocytes;A11.118.413.730;A11.118.290.350.760
Reticulocytes;A15.145.229.413.730;A11.148.378.590.249.760
Reticulocytes;;A15.145.229.334.665.760
Reticulocytes;;A15.378.316.378.590.249.760
Retinal Neoplasms;C04.588.443.363.818;
Retinoblastoma;;C04.588.364.818.760
Retinoblastoma;;C11.319.475.760
Reverse Transcriptase Polymerase Chain Reaction;E05.393.330.500.725;E05.393.620.500.725
Ribosomes;A11.368.702.248.300.651;A11.284.195.190.875.811
Ribosomes;A11.368.702.811;
Ring Chromosomes;;C23.550.210.751
RNA, Catalytic;;D13.444.735.790.199
RNA, Guide;D13.444.735.510;D13.444.735.790.400
RNA, Small Cytoplasmic;D13.444.735.725;D13.444.735.790.530
RNA, Small Nuclear;;D13.444.735.790.545
RNA, Small Nucleolar;;D13.444.735.790.545.800
RNA, Spliced Leader;D13.444.735.730;D13.444.735.790.560
Sarcocystis;B01.841.075.762.167.275.250.600;B01.841.075.189.250.750.750
Sarcocystosis;C03.752.750.259.634;C03.752.250.634
Sarcolemma;A11.195.707;A11.284.149.707
Sarcoma, Endometrial Stromal;;C04.588.945.418.948.585.500
Sarcoma, Endometrial Stromal;;C13.371.270.875.750.500
Sarcoma, Endometrial Stromal;;C13.371.820.800.418.875.200.500
Sarcoma, Endometrial Stromal;;C13.371.852.762.200.500
Sarcomeres;A11.368.702.619.827;A11.284.195.190.875.800
Sarcoplasmic Reticulum;A11.368.702.248.310.800;A11.284.195.190.875.248.310.800
Serial Passage;E05.909.560.837;E05.200.875.837
Serine;;D12.125.154.800
Serotyping;E05.909.560.150.125.890;E05.200.875.150.125.890
Sertoli-Leydig Cell Tumor;;C04.588.322.455.265.500
Sertoli-Leydig Cell Tumor;;C04.588.945.418.685.148.500
Sertoli-Leydig Cell Tumor;;C13.371.056.630.705.132.500
Sertoli-Leydig Cell Tumor;;C13.371.270.750.124.500
Sertoli-Leydig Cell Tumor;;C13.371.820.800.418.685.132.500
Sertoli-Leydig Cell Tumor;;C19.344.455.265.500
Sertoli-Leydig Cell Tumor;;C19.391.630.705.132.500
Serum Bactericidal Test;E05.909.560.595.800;E05.200.875.595.800
Serum Bactericidal Test;;E05.337.550.400.800
Sex Chromatin;A11.223.349.748;A11.284.170.279.190.160.180.383.800
Sex Chromatin;;A11.284.187.865.800
Sex Chromosomes;A11.223.475.865;A11.284.187.865
Shadowing (Histology);E05.909.262.620.670.770;E05.200.500.620.670.770
Shadowing (Histology);E05.909.432.600.670.770;E05.200.750.600.670.770
Shivering;G07.315.232.542;G07.315.232.778.500
Silver Staining;E05.909.262.620.670.780;E05.200.500.620.670.780
Silver Staining;E05.909.432.600.670.780;E05.200.750.600.670.780
SITS;D02.455.426.559.389.150.700.850;D02.455.426.559.389.150.700.050
SITS;D02.500.375.850;D02.500.375.050
SITS;D02.886.250.850;D02.886.250.050
Skull Base Neoplasms;C04.588.443.840.830;
Skull Neoplasms;C04.588.443.840;
Sleep Disorders, Circadian Rhythm;;C10.281.800
Sleep Disorders, Circadian Rhythm;;C21.447.900
Sodium Fluoride;;D25.223.716
Sperm Count;E05.909.262.195.870;E05.200.500.195.870
Sperm Tail;A11.368.702.298.835;A11.284.180.290.835
Spherocytes;A11.118.413.330.802;A11.118.290.330.802
Spherocytes;A15.145.229.413.330.802;A15.145.229.334.330.802
Spliceosomes;A11.368.702.840;A11.284.170.279.830
Staining;E05.909.262.620.670;E05.200.500.620.670
Staining;E05.909.432.600.670;E05.200.750.600.670
Staphylococcal Toxoid;D24.310.794.681;D24.310.894.691.681
Stomach Diverticulum;;C06.273.500
Subcellular Fractions;A11.904;A11.284.835
Submitochondrial Particles;A11.368.702.564.882;A11.284.195.190.875.564.882
Submitochondrial Particles;A11.904.626.882;A11.284.835.626.882
Subrenal Capsule Assay;E05.337.300.250.200.700;E05.337.550.200.900.830
Subrenal Capsule Assay;E05.909.262.388.875;E05.624.850.830
Synapses;A11.195.443.780;A11.284.149.165.420.780
Synaptic Membranes;A11.195.443.780.800;A11.284.149.165.420.780.800
Synaptic Membranes;A11.195.844;A11.284.149.844
Synaptic Vesicles;A11.195.443.780.840;A11.284.195.190.875.190.880.830
Synaptonemal Complex;;A11.284.170.279.190.160.830
Synaptosomes;A11.904.859;A11.284.835.859
Technology, Medical;E05.909;
Teleradiology;;N04.452.515.825.500
Telomere;A11.223.475.910;A11.284.170.279.190.160.845
Tetanus Toxoid;D24.310.794.824;D24.310.894.691.824
Tetracycline Resistance;G05.386.310.898;
Tetracycline Resistance;G05.706.310.898;
Thecoma;;C04.588.322.455.765
Thecoma;;C04.588.945.418.685.797
Thecoma;;C13.371.056.630.705.765
Thecoma;;C13.371.270.750.750
Thecoma;;C13.371.820.800.418.685.765
Thecoma;;C19.344.455.765
Thecoma;;C19.391.630.705.765
Theileria;B01.841.075.762.580.580.700;B01.841.075.600.580.700
Theileria annulata;B01.841.075.762.580.580.700.100;B01.841.075.600.580.700.100
Theileria parva;B01.841.075.762.580.580.700.500;B01.841.075.600.580.700.500
Theileriasis;C03.752.750.823;
Threonine;;D12.125.154.900
Thylakoids;A11.368.702.700.140.800;A11.284.195.190.875.700.140.800
Thymoma;;C04.588.894.949.500
Thymus Neoplasms;;C04.588.894.949
Tight Junctions;A11.195.443.820;A11.284.149.165.420.820
Tin Fluorides;;D25.223.800
Tissue Culture;E05.909.813;E05.200.937
Tissue Embedding;E05.909.262.620.720;E05.200.500.620.720
Tissue Embedding;E05.909.432.600.720;E05.200.750.600.720
Tissue Fixation;E05.909.262.620.760.720;E05.200.500.620.760.720
Tissue Fixation;E05.909.432.600.760.720;E05.200.750.600.760.720
Tissue Preservation;E05.909.262.620.760;E05.200.500.620.760
Tissue Preservation;E05.909.432.600.760;E05.200.750.600.760
Torture;I01.198.240.856.675;I01.198.240.856.825
Torture;I01.880.735.900.675;I01.880.735.900.825
Toxoids;D24.310.794;D24.310.894.691
Toxoplasma;B01.841.075.762.167.275.250.650;B01.841.075.189.250.750.800
Toxoplasmosis;C03.752.750.259.800;C03.752.250.800
Toxoplasmosis, Animal;C03.752.750.259.800.110;C03.752.250.800.110
Toxoplasmosis, Cerebral;C03.752.750.259.800.250;C03.752.250.800.250
Toxoplasmosis, Congenital;C03.752.750.259.800.445;C03.752.250.800.445
Toxoplasmosis, Ocular;C03.752.750.259.800.640;C03.752.250.800.640
Transduction, Genetic;G05.825.700.795;E05.393.350.800
Transduction, Genetic;;G05.825.390.850
Transfection;G04.185.515.860;G05.825.390.855
Transfection;G05.386.860;
Transfection;G05.825.700.810;
Transformation, Bacterial;G05.825.700.820;E05.393.350.810.500
Transformation, Bacterial;;G04.185.515.870
Transformation, Bacterial;;G05.825.390.927.820
Transformation, Genetic;G05.825.700;G05.825.390.927
Translocation (Genetics);;C23.550.210.764
Transplantation Chimera;G05.148.630.218.750;B01.030.530.750
Transplantation Chimera;;B02.158.530.750
Tretinoin;D02.455.849.291.700.780;D02.455.849.291.700.818.800
Trimethoprim Resistance;G05.386.310.925;
Trimethoprim Resistance;G05.706.310.925;
Trinucleotide Repeat Expansion;;G05.632.900
Trisomy;;C23.550.210.131.750
Tuberculosis, Lymph Node;;C15.604.315.809
Tumor Stem Cell Assay;E05.337.300.250.200.800;E05.200.500.383.910
Tumor Stem Cell Assay;E05.909.262.383.910;E05.200.500.388.930
Tumor Stem Cell Assay;E05.909.262.388.930;E05.337.550.200.800
Two-Hybrid System Techniques;G05.331.120.870;
Typhoid-Paratyphoid Vaccines;D24.310.894.135.910;D24.310.894.135.685.910
Untranslated Regions;G05.331.599.110.875;D13.444.735.790.878
Untranslated Regions;G06.184.599.110.875;G05.331.599.110.275.880
Untranslated Regions;;G06.184.599.110.220.880
3' Untranslated Regions;G05.331.599.110.875.880;D13.444.735.790.878.880
3' Untranslated Regions;G06.184.599.110.875.880;G05.331.599.110.275.880.880
3' Untranslated Regions;;G06.184.599.110.220.880.880
5' Untranslated Regions;G05.331.599.110.875.885;D13.444.735.790.878.885
5' Untranslated Regions;G06.184.599.110.875.885;G05.331.599.110.275.880.885
5' Untranslated Regions;;G06.184.599.110.220.880.885
Uveal Neoplasms;C04.588.443.363.978;
Vacuoles;A11.368.702.929;A11.284.195.190.875.190.920
Vancomycin Resistance;G05.386.310.960;
Vancomycin Resistance;G05.706.310.960;
Vault Ribonucleoprotein Particles;A11.368.702.930;A11.284.195.190.875.930
Viral Load;E05.909.560.950;E05.200.875.950
Virus Cultivation;E05.909.560.970;E05.200.875.970
Vitamin E;;D03.438.150.819
Water Loss, Insensible;G07.315.232.863;G06.184.963.750
Water Loss, Insensible;G10.795.869.821;G07.621.888.750
Weibel-Palade Bodies;A11.368.246.950;A11.284.195.190.500.950
Weibel-Palade Bodies;A11.515.246.950;A11.284.195.190.875.190.190.950
Williams Syndrome;C14.280.484.150.800;C14.280.484.150.060.960
X Chromosome;A11.223.475.865.982;A11.284.187.865.982
Xenodiagnosis;E05.909.560.985;E05.200.875.985
Y Chromosome;A11.223.475.865.983;A11.284.187.865.983
Zenker Diverticulum;;C06.273.250.900
Zona Pellucida;;A11.284.295.310.990
